GREY:ATBPF - Post by User
Comment by
Sanderzon Mar 27, 2018 2:44pm
74 Views
Post# 27788811
RE:RE:I think
RE:RE:I thinkPandora wrote: Sanderz wrote: people here overhyped this stock. And before you read further, know that I DO have shares here, I bought shares in the early 0.50's I believe. No doubt the last news release was a good milestone for this company. I'm not knocking the company itself, but this stock was overhyped by the market, internet articles, and the people here. If this drug is going to be SUCH A BIG DEAL, then this would be trading much much higher. It may trade much higher further down the road, but not right now obviously. People generally aren't stupid; if this was a BIG deal, it would be bought up much higher.
There is another aspirin alternative on nasdaq (PLXP) which I talked to Dan about. He felt the ATB346 is a better product but then he is also biased. PLXP was trading in the $6.50 area but recent quarterly results knocked it down to the $3.50 area. Wouldn't we like to even be there.
PLXP has approx. 30 million market cap and ATE's market cap is more than twice that, So if anything, ATE might even be overvalued at this point..